Join a Legacy of Innovation 110 Years and Counting!
Daiichi Sankyo Group is dedicated to the creation and supply of innovative pharmaceutical therapies to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class science and technology. With more than 100 years of scientific expertise and a presence in more than 20 countries, Daiichi Sankyo and its 16,000 employees around the world draw upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people. Under the Group’s 2025 Vision to become a “Global Pharma Innovator with Competitive Advantage in Oncology,” Daiichi Sankyo is primarily focused on providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders.
Summary
US Medical Affairs leader for assigned compound under the supervision and leadership of the Executive Director of Medical Research and Strategy, US Oncology Medical Affairs (USOMA). Develops the USOMA strategy and tactical plan as part of the US Brand Strategic Plan and leads the execution of the activities in the USOMA plan including Launch Readiness and Life Cycle Management. Leads the team for this compound.
Responsibilities
- Responsible for the development of the USOMA strategy and medical objectives for the assigned compound and leads development and execution of the US Medical Affairs plan and budget management including activities related to evidence generation, scientific engagement and communication as part of Launch Readiness activities and life cycle management from a medical perspective.
- Participates in Global Medical Affairs committees as requested. Serves as US Medical Affairs Lead, to gain strategic and planning alignment across the matrix team and the core USOMA functions. Represents US medical affairs function as a member of the various cross-functional forums including, Publications Planning, Clinical and Safety sub-teams, US and Global Brand Team, and US Product Team to inform clinical development, commercialization, market access, and other cross-functional strategic discussions.
- Provides medical leadership: Leads USOMA teams as part of evidence generation forums and study teams for Local/Regional Medical Affairs company sponsored study concepts as needed. Partners with RWE and HEOR strategy and Biomarker/CDx leads on related integrated evidence generation strategies and activities as part of the USOMA Plan. Provides medical review of expanded access programs (EAP) and, investigator-initiated studies (IIS) as part of a US IIS Review Committee, for assigned compound. Collaborates with Global Medical Affairs and across USOMA functions to develop, review, and align on key scientific communications and medical information response documents within legal and compliance regulations. Leads internal stakeholder medical education activities related to the compound data. In partnership with Medical Intelligence and Congress Planning leads, communicates and educates on related competitor data. Provides medical leadership in scientific engagement activities with key external stakeholders such as advisory boards, investigator interactions, congress activities, peer to peer discussions with key thought leaders. Provides medical support for scientific symposium and medical congresses within legal and compliance regulations. Works with Patient Advocacy leads and Grants office to incorporate the patient voice and define external medical education strategies for independent grants, respectively. Provides input into publication strategy, data gap analysis, and tactical planning as part of the overall USOMA plan. Reviews and approves abstracts, manuscripts, and other data disclosure documents.
- Attract and develop USOMA talent. Provides coaching, direction, feedback and guidance as needed. Evaluate team progress against goals/objectives. Manage budgets and resources efficiently for USOMA supported activities within the USOMA plan, is required. Experience in collaboration with US Oncology Franchise Head oncology therapeutic area is required.
Qualifications: Successful candidates will be able to meet the qualifications below with or without a reasonable accommodation.
Education Qualifications (from an accredited college or university)
- An advanced doctorate degree (PharmD, PhD, MD, DO or equivalent) in medical/scientific area required.
- MD preferred.
- Experience in oncology therapeutic area required.
Experience Qualifications
- 10 or More Years Pharmaceutical industry experience or commensurate healthcare or research experience required.
- 4 or More Years Minimum of 5 years of (in-house) medical affairs or related experience, US preferred required.
- Must have oncology experience, specifically in solid tumors.
- Previous overall responsibility and accountability for multiple indications of one or more compounds and related USOMA plan/budget for related MA activities.
- Demonstrated ability to lead and influence others internally and externally. Experience leading matrix medical teams and representing medical on cross-functional leadership teams (e.g. US Product Team, US Brand Team, Global Medical Team, etc.). Relationships with or proven history developing key external experts. Proven ability to manage multiple priorities at one time required.
- Knowledge of ADC or other biologics, or small molecules.
- Demonstrated experience working with an alliance partner company preferred.
Travel
Ability to travel up to 20%.
Daiichi Sankyo, Inc. is an equal opportunity/affirmative action employer. Qualified applicants will receive consideration for employment without regard to sex, gender identity, sexual orientation, race, color, religion, national origin, disability, protected veteran status, age, or any other characteristic protected by law.
#J-18808-Ljbffr
